Assyro AI

Orange Book product · Brand (NDA)

ACTOPLUS MET XR

METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE

Brand (NDA)NDA 022024DISCN TAKEDA PHARMS USA

At a glance

May 12, 2009

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 12, 2009

    17 yr 4 mo ago

  2. Today

  3. Patent 7785627 expires

    Listed drug product patent expiration.

    Jul 31, 2026

    in 1 mo

  4. Patent 7959946 expires

    Listed drug product patent expiration.

    Jul 31, 2026

    in 1 mo

Pharmaceutical detail

Active ingredient

METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE

Strength

1GM;EQ 15MG BASE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

TE code

Not listed

Application

NDA 022024

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7785627Jul 31, 2026in 1 mo
Product
7959946Jul 31, 2026in 1 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.